See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Baseball
Nintendo
Donald Trump
Natural Disasters
Social Media
European Union
Trade War
Taxes
Golf
Senate
Trade
Published • loading... • Updated

Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK - Pharmaceutical Technology

Summary by Pharmaceutical-technology.com
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease caused by RSV.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Express PharmaExpress Pharma

Pfizer’s ABRYSVO gains EU approval for RSV prevention in adults 18-59 - Express Pharma

Pfizer announced that the European Commission (EC) has amended the marketing authorisation for ABRYSVO, the company’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to include the prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals aged 18 to 59. The expansion builds on the existing authorisation for individuals aged 60 and older. The updated indication allows for active immunisation of in…

Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK - Pharmaceutical Technology

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease caused by RSV.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccines

Vaccines

European Union

European Union

European Commission

European Commission

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal